Recent Finacing
Recent Raise
Okairos is clinical-stage biopharmaceutical company developing T-cell–engaging prophylactic and therapeutic vaccines against infectious diseases (malaria, HIV, HCV, universal influenza) and cancer, based in Basel with labs in Rome and Naples.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors